Gastric inhibitory polypeptide in newly diagnosed ketotic type I (insulin-dependent) diabetics.

@article{Krarup1988GastricIP,
  title={Gastric inhibitory polypeptide in newly diagnosed ketotic type I (insulin-dependent) diabetics.},
  author={T Krarup and Sten Madsbad and Alan John Moody},
  journal={Acta medica Scandinavica},
  year={1988},
  volume={223 5},
  pages={437-41}
}
Plasma concentrations of 5,000 daltons (5 kDa) immunoreactive gastric inhibitory polypeptide (IR-GIP) were measured before and up to 16 hours after the start of low-dose insulin treatment in newly diagnosed ketotic type I (insulin-dependent) diabetics. Nine patients were non-fasting. Before insulin treatment mean IR-GIP was 31 +/- 6 pmol/l (range 9-65 pmol/l). Four patients had IR-GIP concentrations in the normal fasting range (10-25 pmol/l), and nine patients had concentrations below 35 pmol/l… CONTINUE READING